The Kidney Innovation Accelerator (KidneyX) is a public-private partnership between the U.S. Department of Health and Human Services (HHS) and the American Society of Nephrology (ASN). By accelerating innovation in the prevention, diagnosis, and treatment of kidney diseases, KidneyX seeks to improve the lives of people with kidney diseases by expediting the development of drugs, devices, biologics, and other therapies across the spectrum of kidney care.
The Artificial Kidney Prize builds on past KidneyX competitions but is distinct in its goal: to accelerate the development of continuous kidney replacement therapies that provide transformational treatment options beyond current dialysis methods.
To date, KidneyX has completed three competitions: the Patient Innovator Challenge and Redesign Dialysis Phase 1 and Phase 2. These competitions sought to improve the quality of life for people with kidney failure by improving current dialysis treatment through innovations that reduce infection risk, improve vascular access, and replace kidney functions. KidneyX has awarded over $4 million to winners of these competitions.
For this competition, artificial kidneys may be wearable, implantable, bioengineered, developed as a xenotransplant or chimera organ, or other approaches not yet conceived. The competition aims to bring these artificial kidney solutions toward human clinical trials with a greater level of maturity, functionality, and potential for patient impact than is currently possible. With the Artificial Kidney Prize, HHS and ASN intend to stimulate the market for further kidney health innovation, drawing greater participation and capital. Additionally, through fostering a collaborative solver community, the competition will support the development of cross-disciplinary solutions necessary for success.
The competition will award up to $10 million. Up to $4 million in Phase 1 prizes will be distributed among up to eight Phase 1 winners, at the discretion of HHS and ASN. For Phase 2, up to $6 million in prizes will be distributed to winners at the discretion of HHS and ASN. Up to $2.5 million in prizes will be awarded by HHS over Phases 1-2; up to $7.5 million in prizes will be awarded by ASN over Phases 1-2.
Submissions will close at 4:59 p.m. EDT on March 24, 2021.
URL for more information:
See the official rules, terms, and conditions for further details.
Filed Under: Funding Opportunities